Tag Archives: semaglutide

The FDA warns against the compound semaglutide

The United States Food and Drug Administration (FDA) warns against going to compounding pharmacies for generic versions of semaglutide, the active ingredient in Wegovy and Ozempic. Compound drugs can mix, combine, or alter ingredients to create drugs that are tailored to the needs of individual patients. Medicines can be compounded when there is a shortage… Read More »